Eurobio Scientific Société anonyme (EPA:ALERS)
France · Delayed Price · Currency is EUR 21.90
-0.70 (-3.10%)
Jun 3, 2026, 4:47 PM CET
EPA:ALERS Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 4.87 | 4 | 4.84 | 24.94 | 60.54 |
Depreciation & Amortization | 11.7 | 14.06 | 13.15 | 9.63 | 7.87 |
Other Amortization | 4.9 | - | - | - | - |
Loss (Gain) From Sale of Assets | 0.31 | 0.07 | 0.06 | -1.77 | - |
Other Operating Activities | 1.33 | 2.88 | 0.39 | 1.43 | 1.17 |
Change in Accounts Receivable | -3.23 | -2.84 | 12.9 | 20.84 | 2.05 |
Change in Inventory | -1.92 | -3.84 | 2.04 | 0.24 | -3.3 |
Change in Accounts Payable | 0.74 | 2.4 | - | - | - |
Change in Unearned Revenue | 0.12 | -0.08 | -0.24 | 0.28 | -0.03 |
Change in Other Net Operating Assets | 0.05 | 0.07 | -6.35 | -12.52 | -2.39 |
Operating Cash Flow | 18.85 | 16.7 | 26.77 | 43.07 | 65.92 |
Operating Cash Flow Growth | 12.87% | -37.60% | -37.86% | -34.66% | 20.00% |
Capital Expenditures | -12.57 | -3.26 | -4.05 | -2.83 | -1.85 |
Sale of Property, Plant & Equipment | 0.02 | 0.17 | 1.9 | 2.52 | 0.1 |
Cash Acquisitions | -0.59 | -10.12 | -4.5 | -132.16 | - |
Investment in Securities | 0.25 | 2.47 | 6.34 | -9.28 | -3.72 |
Other Investing Activities | - | -0 | - | - | 0 |
Investing Cash Flow | -12.89 | -10.74 | -0.32 | -141.76 | -5.47 |
Short-Term Debt Issued | - | 23.45 | - | - | - |
Long-Term Debt Issued | 8 | - | - | 105 | - |
Total Debt Issued | 8 | 23.45 | - | 105 | - |
Short-Term Debt Repaid | -10.86 | - | - | - | - |
Long-Term Debt Repaid | -3.59 | -92.72 | -18.2 | -9.25 | -15.96 |
Total Debt Repaid | -14.44 | -92.72 | -18.2 | -9.25 | -15.96 |
Net Debt Issued (Repaid) | -6.44 | -69.27 | -18.2 | 95.75 | -15.96 |
Repurchase of Common Stock | - | -0.15 | -2.79 | -12.24 | -6.91 |
Other Financing Activities | -1.72 | -2.67 | -2.51 | -1.21 | -0.88 |
Financing Cash Flow | -8.16 | -72.09 | -23.5 | 82.31 | -23.76 |
Foreign Exchange Rate Adjustments | -0.2 | 0.16 | 0.15 | -0.08 | 0.14 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - |
Net Cash Flow | -2.4 | -65.96 | 3.09 | -16.45 | 36.83 |
Free Cash Flow | 6.28 | 13.45 | 22.71 | 40.24 | 64.07 |
Free Cash Flow Growth | -53.28% | -40.80% | -43.55% | -37.19% | 21.73% |
Free Cash Flow Margin | 3.73% | 8.70% | 17.39% | 26.32% | 34.57% |
Free Cash Flow Per Share | 0.61 | 1.31 | 2.02 | 3.54 | 5.89 |
Cash Interest Paid | 1.72 | 2.66 | 2.47 | 1.23 | 0.46 |
Levered Free Cash Flow | 6.3 | 0.7 | 16.39 | 44.88 | 46.34 |
Unlevered Free Cash Flow | 7.51 | 3.28 | 19.11 | 45.67 | 46.6 |
Change in Working Capital | -4.24 | -4.3 | 8.35 | 8.84 | -3.67 |